Microfluidics: the fur-free way towards personalised medicine in cancer therapy.
2016
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
10.1038/s41598-018-22749-0 · 2018
Organs-on-a-chip engineering.
10.1016/b978-0-12-817202-5.00003-6 · 2020
Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.
10.14573/altex.1603161 · 2016
First EMA workshop on non-animal approaches in support of medicinal product development: challenges and opportunities for use of micro-physiological systems.
2017
Non-Animal Approaches the Way Forward.
10.2779/373944 · 2016
Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce animal testing through a study aimed at eliminating the use of dogs in certain trials.
Kept as external metadata until matched
Administrator Wheeler Signs Memo to Reduce Animal Testing, Awards $4.25 Million to Advance Research on Alternative Methods to Animal Testing.
Kept as external metadata until matched
Impact of organ-on-a-chip technology on pharmaceutical R&D costs.
10.1016/j.drudis.2019.06.003 · 2019
The Emergence of Microphysiological Systems (Organs-on-chips) as Paradigm-changing Tools for Toxicologic Pathology.
10.1177/0192623318809065 · 2019
Organ-on-chip Market Expected to reach $170 Million, Globally, by 2023.
Kept as external metadata until matched
Organ-on-Chip Market 2019 - Industry Analysis, Size, Share, Strategies and Forecast to 2023.
Kept as external metadata until matched
Organ-on-chip Market by Type (Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, and Lung-on-chip) - Global Opportunity Analysis and Industry Forecast, 2017-2023.
Kept as external metadata until matched
Organ-on-Chip Market by Offering (Services, Products), by Type (Liver-on-Chip, Lung-on-Chip, Kidney-on-Chip, Heart-on-Chip, Intestine-on-Chip, Brain-on-Chip), by Application (Toxicology Research, Physiological Model Development, Drug Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), by Geography (U.S., Canada, Germany, U.K., France, China, Japan) – Global Market Size, Share, Development, Growth and Demand Forecast, 2016–2025.
Kept as external metadata until matched
Microfluidics Market Size, Share & Trends Analysis Report By Application (Lab-on-a-Chip, Organs-on-Chips, Continuous Flow), By Technology (Medical, Non-Medical), By Material, And Segment Forecasts, 2020 - 2027.
Kept as external metadata until matched
Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025.
Kept as external metadata until matched
Microfluidics Market - Growth, Trends, and Forecasts (2020 - 2025).
Kept as external metadata until matched
An introduction to drug disposition: The basic principles of absorption, distribution, metabolism, and excretion.
10.1177/019262339502300202 · 1995
Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.
10.14573/altex.1610101 · 2016
FDA's Woodcock: The Clinical Trials System is 'Broken'.
Kept as external metadata until matched
FDA's Woodcock: 'The clinical trial system is broken'.
Kept as external metadata until matched
Estimation of clinical trial success rates and related parameters.
10.1093/biostatistics/kxx069 · 2019
The cost of drug development.
10.1056/nejmc1504317 · 2015
A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate for Drugs Entering Clinical Development is Less Than 12%.
Kept as external metadata until matched
Getting A Handle On Clinical Trial Costs.
Kept as external metadata until matched
How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
10.1007/s40258-016-0300-z · 2017
The cost of pharmaceutical innovation to patients.
10.1517/17460441.2.11.1431 · 2007
Create a translational medicine knowledge repository--Research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: How will they avoid relearning old lessons?
10.1186/1479-5876-9-56 · 2011
Outsourcing Clinical Trials Outside of the US.
Kept as external metadata until matched
Partnering with the right CRO is a winning strategy for companies big and small.
Kept as external metadata until matched
Pharma is shuffling around jobs, but a skills gap threatens the process.
Kept as external metadata until matched
MImETIC INDiRECT-ED001.
2021
Henrietta Lacks, HeLa cells, and cell culture contamination.
10.5858/133.9.1463 · 2009
Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
10.1007/978-3-319-33826-2_4 · 2016
Organ-on-Chip In Development: Towards a European roadmap for Organ-on-Chip.
2018
Diffusion of innovations theory, principles, and practice.
10.1377/hlthaff.2017.1104 · 2018
Horizon 2020 Work Programme 2014-2015 General Annexes.
Kept as external metadata until matched
Measuring Technology Readiness for Investment: Accelerating Technology Development and Improving Innovation Performance
2017
An Approach for Developing Concept of Innovation Readiness Levels.
2011
A Survey of Technology Readiness Level Users.
10.1002/j.2334-5837.2016.00283.x · 2016
